About Us   |   Contact Us
An International Publisher for Academic and Scientific Journals
Author Login 
 Author Login
Submit Manuscript
Join Membership
Join As Reviewer
Join As Editor
Pay Publication Fee
Subscribe Hard Copy
Scholars Journal of Medical Case Reports | Volume-10 | Issue-02
Inhabituel Toxicity of Sorafenib: Eryhema Multiform: A New Case Report and Review
Lamia Aalaoui, Anouar Mokhlis, Mohamed Reda Khmamouche, RachidTanz, Hassan Errihani, Mohamed Ichou
Published: Feb. 13, 2022 | 140 86
DOI: 10.36347/sjmcr.2022.v10i02.010
Pages: 92-93
Downloads
Abstract
Sorafenib, an oral small molecule multikinase inhibitor indicated for the treatment of some solid tumors, has been associated with a variety of cutaneous adverse events. Erythema multiforme is one of the extremely rare skin toxicities reported. We present this interesting case to show and discuss the cutaneous side effects of sorafenib, in particular the erythema multiforme that occurred in a woman treated for metastatic hepatocellular cancer after only five days of treatment.